Mississippi official pleads guilty in welfare scandal that involves Brett Favre

Mississippi official pleads guilty in welfare scandal that involves Brett Favre


John Davis, former director of the Mississippi Department of Human Services, enters the Thad Cochran United States Courthouse in Jackson, Miss., Thursday, Sept. 22, 2022, where he is set to plead guilty to new federal charges in a conspiracy to misspend tens of millions of dollars that were intended to help needy families.

Rogelio V. Solis | AP

A key figure in Mississippi’s welfare spending scandal has pleaded guilty to federal fraud charges under an arrangement that signals he may be cooperating, according to court records.

John Davis directed Mississippi’s welfare agency while it doled out millions of dollars in federal welfare money to projects investigators now say were improper, including a new volleyball facility requested by former NFL quarterback Brett Favre that benefited his daughter.

According to court records, Davis agreed to plead guilty to conspiracy to commit fraud and theft — charges that together carry a maximum of 15 years in prison.

“At Davis’s direction, (Mississippi’s welfare agency) provided federal funds to two nonprofit organizations and then directed the two nonprofit organizations to fraudulently award contracts to various entities and individuals for social services that were never provided,” the Justice Department said in a news release.

The plea represents the first federal prosecutorial action in the two-year-old scandal, though another main player has been indicted on unrelated federal charges.

Davis worked for then-Gov. Phil Bryant, who has consistently denied that he was aware that federal welfare money was being used for the projects, in violation of state and federal laws.

As NBC News has previously reported, Davis was involved in discussions with Bryant and Favre about securing millions of dollars for the volleyball facility. Favre also secured $3.2 million for a drug company in which he had invested, according to court records.

Nancy New, a former nonprofit executive who also is cooperating after a guilty plea, distributed the money in consultation with Davis and the governor, court records show.

In complex investigations, prosecutors often try to secure cooperation from some defendants who they hope will testify against people who directed them. The only figure higher than Davis, the welfare director, is Bryant. He has denied wrongdoing.

Favre has also denied wrongdoing through his lawyer, who acknowledged that Favre has been interviewed by the FBI. There is no indication Favre is a target of the investigation, and he says he did not know the state grants came from federal welfare funds.

The scandal has drawn outrage, in part because Mississippi is the poorest state in the nation and one of the stingiest when it comes to the number of families who are deemed eligible for federal welfare help.



Source

CDC says there are no U.S. hantavirus cases currently, 41 people being monitored
Business

CDC says there are no U.S. hantavirus cases currently, 41 people being monitored

In this photo illustration Hantavirus samples are seen in Ankara, Turkiye on May 6, 2026. Arman Onal | Anadolu | Getty Images The U.S. Centers for Disease Control and Prevention said there are no hantavirus cases in the country as of Thursday, as it monitors 41 people for the virus. The agency said the risk […]

Read More
These three artworks could sell for 0 million each next week as May auctions begin
Business

These three artworks could sell for $100 million each next week as May auctions begin

A large-scale Jackson Pollock drip painting titled, “Number 7A, 1948.” Crystal Lau | CNBC A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. Nearly $2 billion worth of art will come up […]

Read More
Biogen advances Alzheimer’s drug to late-stage trial despite disappointing data
Business

Biogen advances Alzheimer’s drug to late-stage trial despite disappointing data

A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen plans to advance an experimental drug for Alzheimer’s disease to late-stage testing despite disappointing mid-stage trial data, the company said Thursday. Biogen said its experimental drug that targets tau, a protein associated with the memory-robbing disease, failed to show better responses at higher doses. […]

Read More